SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028358
Filing Date
2021-11-15
Accepted
2021-11-15 09:03:57
Documents
79
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1620472
2 ex10-2.htm EX-10.2 376945
3 ex31-1.htm EX-31.1 19302
4 ex31-2.htm EX-31.2 19839
5 ex32-1.htm EX-32.1 8028
  Complete submission text file 0001493152-21-028358.txt   7308543

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20210930.xsd EX-101.SCH 57470
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsn-20210930_cal.xml EX-101.CAL 71823
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsn-20210930_def.xml EX-101.DEF 222742
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20210930_lab.xml EX-101.LAB 458707
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20210930_pre.xml EX-101.PRE 343527
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 956473
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 211406733
SIC: 2834 Pharmaceutical Preparations